Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PSEN1 | P49768 | 11/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PDE4A | P27815 | 1/20 | 0.40 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.40 |
| ▸ | GSTO1 | P78417 | 2/20 | 0.39 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.39 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15854991 | 0.84 | PSEN1 (0.43) | PSEN1MEN1KMT2APDE4APDE3A | |
| SCHEMBL5165669 | 0.83 | PSEN1 (0.43) | PSEN1MEN1KMT2APDE4APDE3A | |
| SCHEMBL9632542 | 0.83 | PSEN1 (0.45) | PSEN1MEN1KMT2APDE4APDE3A | |
| SCHEMBL9074319 | 0.83 | PSEN1 (0.43) | PSEN1MEN1KMT2APDE4APDE3A | |
| SCHEMBL9074313 | 0.83 | PSEN1 (0.43) | PSEN1MEN1KMT2APDE4APDE3A | |
| SCHEMBL1285802 | 0.82 | PSEN1 (0.42) | PSEN1MEN1KMT2APDE4APDE3A | |
| SCHEMBL9075342 | 0.81 | PSEN1 (0.46) | PSEN1MEN1KMT2APDE4APDE3A | |
| SCHEMBL4867433 | 0.81 | PSEN1 (0.48) | PSEN1MEN1KMT2APDE4APDE3A | |
| SCHEMBL11601582 | 0.80 | PSEN1 (0.42) | PSEN1MEN1KMT2APDE4APDE3A | |
| SCHEMBL11601587 | 0.80 | PSEN1 (0.42) | PSEN1MEN1KMT2APDE4APDE3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5508450-A | INHIBITORY EFFECT ON MAILLARD REACTION AND ANTIOXIDIZING EFFECT; TREATS OR PREVENTS DIABETIC COMPLICATIONS | ONO PHARMACEUTICAL CO., LTD. (JP) | 1996-04-16 | — | — | US | disclosed |
| EP-0387771-B1 | Benzopyran derivatives | ONO PHARMACEUTICAL CO (JP) | 1995-06-07 | — | — | EP | disclosed |
| US-5384414-A | Compounds with guanidine groups | ONO PHARMACEUTICAL CO., LTD. (JP) | 1995-01-24 | — | — | US | disclosed |
| US-5266709-A | Treatment of diabetic complications | ONO PHARMACEUTICAL CO., LTD. (JP) | 1993-11-30 | — | — | US | disclosed |
| US-5169957-A | Antidiabetic agents | ONO PHARMACEUTICAL CO., LTD. (JP) | 1992-12-08 | — | — | US | disclosed |
| US-5055598-A | Prevention and treatment of diabetic complications, diseases of aging and formation of peroxidized fat; antioxidants | ONO PHARMACEUTICAL CO., LTD. (JP) | 1991-10-08 | — | — | US | disclosed |
| EP-0387771-A2 | Benzopyran derivatives | ONO PHARMACEUTICAL CO., LTD. (JP) | 1990-09-19 | — | — | EP | disclosed |